Lloyd E. Johnson - Jul 24, 2025 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Role
Director
Signature
/s/ Thomas V. Powers, attorney-in-fact for Mr. Johnson
Stock symbol
HAE
Transactions as of
Jul 24, 2025
Transactions value $
$0
Form type
4
Date filed
7/25/2025, 04:28 PM
Previous filing
Jul 2, 2025
Next filing
Oct 2, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Johnson Lloyd Emerson Director 125 SUMMER STREET, BOSTON /s/ Thomas V. Powers, attorney-in-fact for Mr. Johnson 2025-07-25 0001708823

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HAE Common Stock Award +2.69K +26.3% 12.9K Jul 24, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant.
F2 Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.